Global Small Molecule Prefilled Syringes Market- Regional Analysis
Among region, North America is estimated to hold a dominant position in the global small molecule prefilled syringes market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2023. North America small molecule prefilled syringes market is expected to witness significant growth in thenear future due toincreasing product approvals by the regulatory authorities. For instance, in February 2022, Takeda Pharmaceutical Company Limited, a pharmaceutical company, announced that it had received approval by the U.S. Food and Drug Administration (FDA) for its single-dose prefilled injection syringe (PFS) named TAKHZYRO (lanadelumab-flyo) for the prevention of attacks of hereditary angioedema (HAE) in adult and pediatric patients of age 12 years and older. The PFS is ready-to-use and requires fewer preparation steps than the current TAKHZYRO vial injection, while reducing supplies and waste.
Small Molecule Prefilled Syringes Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients